2-aminoN-hydroxy-3-(1H-indol-3-yl)-propionimidic acid

ID: ALA490034

Chembl Id: CHEMBL490034

PubChem CID: 667595

Max Phase: Preclinical

Molecular Formula: C11H13N3O2

Molecular Weight: 219.24

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NO

Standard InChI:  InChI=1S/C11H13N3O2/c12-9(11(15)14-16)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13,16H,5,12H2,(H,14,15)/t9-/m0/s1

Standard InChI Key:  LBMAEBPZXXNKMZ-VIFPVBQESA-N

Alternative Forms

  1. Parent:

Associated Targets(Human)

SLC7A5 Tchem L-type amino acid transporter 1 (388 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

lpxC UDP-3-O-acyl-GlcNAc deacetylase (448 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ispF 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ispF 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 219.24Molecular Weight (Monoisotopic): 219.1008AlogP: 0.54#Rotatable Bonds: 3
Polar Surface Area: 91.14Molecular Species: NEUTRALHBA: 3HBD: 4
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 8.79CX Basic pKa: 7.53CX LogP: 0.13CX LogD: -0.07
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.45Np Likeness Score: 0.09

References

1. Ramsden NL, Buetow L, Dawson A, Kemp LA, Ulaganathan V, Brenk R, Klebe G, Hunter WN..  (2009)  A structure-based approach to ligand discovery for 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase: a target for antimicrobial therapy.,  52  (8): [PMID:19320487] [10.1021/jm801475n]
2. Zur AA,Chien HC,Augustyn E,Flint A,Heeren N,Finke K,Hernandez C,Hansen L,Miller S,Lin L,Giacomini KM,Colas C,Schlessinger A,Thomas AA.  (2016)  LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates.,  26  (20.0): [PMID:27624080] [10.1016/j.bmcl.2016.09.001]
3. Blain JM, Grote DL, Watkins SM, Goshu GM, Muller C, Gorman JL, Ranieri G, Walter RL, Hofstetter H, Horn JR, Hagen TJ..  (2021)  Structural and biophysical characterization of the Burkholderia pseudomallei IspF inhibitor L-tryptophan hydroxamate.,  48  [PMID:34298132] [10.1016/j.bmcl.2021.128273]

Source